Goldman Sachs’s Pediatrix Medical MD Stock Holding History

Goldman Sachs’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-28,000	Closed	-$1.31M	–	5495
2018 Q3	$1.31M	Hold	28,000	–	–	﹤0.01%	3885
2018 Q2	$1.21M	Sell	28,000 -47,000	-63%	-$2.25M	﹤0.01%	3954
2018 Q1	$4.17M	Sell	75,000 -10,500	-12%	-$576K	﹤0.01%	3044
2017 Q4	$4.57M	Buy	+85,500	New	+$4.03M	﹤0.01%	3080
2014 Q4	–	Sell	-50,200	Closed	-$2.75M	–	7229
2014 Q3	$2.75M	Buy	+50,200	New	+$2.85M	﹤0.01%	3612
2013 Q4	–	Sell	-76,400	Closed	-$3.83M	–	6743
2013 Q3	$3.83M	Sell	76,400 -2,400	-3%	-$117K	﹤0.01%	3222
2013 Q2	$3.61M	Buy	+78,800	New	+$3.53M	﹤0.01%	3074

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Goldman Sachs's MD Position: Q2 2026 in Review

Goldman Sachs reduced its Pediatrix Medical (MD) stake by 3% in Q2 2026, selling an estimated $588K and leaving 825,636 shares worth $20.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2585.

Goldman Sachs first reported a position in MD in Q2 2013 and has held it in 53 quarters since. The position peaked at $86M in Q4 2016. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

Goldman Sachs held 825,636 shares of Pediatrix Medical worth $20.9M as of Q2 2026.
Goldman Sachs sold 25,828 Pediatrix Medical shares in Q2 2026, an estimated $588K.
Pediatrix Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2585 holding.
Goldman Sachs first reported a position in Pediatrix Medical in Q2 2013 and has held it in 53 quarters since.
Goldman Sachs's Pediatrix Medical position peaked at $86M in Q4 2016.
304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.